Showing results (81-90 of 162) with videos related to
Sort By:
Pageof 17
Aging|August 22, 2019
Prognostic value of long non-coding RNA signatures in bladder cancerAnbang He, Shiming He, Ding Peng, et al.ESC Heart Failure|April 2, 2025
BUN-to-ALB ratio as an effective predictor of 30 day mortality in ADHF patients in eastern ChinaXin Huang, Chao Wang, Shiming He, et al.International Journal of Biological Sciences|February 17, 2022
Ascorbic acid induced TET2 enzyme activation enhances cancer immunotherapy efficacy in renal cell carcinomaDing Peng, Anbang He, Shiming He, et al.BMJ Open|April 18, 2023
Effectiveness and safety of implementing an enhanced patient comfort programme for elective neurosurgical patients: a randomised controlled trial protocolBolin Liu, Shujuan Liu, Binrong Wang, et al.Aging|November 22, 2020
Identification of immune-related LncRNA for predicting prognosis and immunotherapeutic response in bladder cancerYucai Wu, Lei Zhang, Shiming He, et al.Medicine|August 19, 2022
Neurosurgical enhanced recovery after surgery ERAS for geriatric patients undergoing elective craniotomy: A reviewBolin Liu, Shujuan Liu, Tao Zheng, et al.Neuro-Oncology|December 25, 2013
Association between leukocyte telomere length and glioma risk: a case-control studyShaolong Wang, Yibing Chen, Falin Qu, et al.Frontiers in Endocrinology|April 7, 2025
Association between estimated glucose disposal rate and prediabetes reversion and progression: a nationwide cohort study of middle-aged and elderly people in ChinaXin Huang, Shiming He, Chao Wang, et al.Journal of Biomedicine & Biotechnology|April 13, 2012
Aberrant expression of N-methylpurine-DNA glycosylase influences patient survival in malignant gliomasCe Liu, Yanyang Tu, Jun Yuan, et al.Heliyon|March 6, 2023
Cytoskeleton regulator RNA expression on cancer-associated fibroblasts is associated with prognosis and immunotherapy response in bladder cancerYucai Wu, Yangyang Xu, Shiming He, et al.Pageof 17